Skip to main content
Eurazeo SE logo

Eurazeo SE — Investor Relations & Filings

Ticker · RF ISIN · FR0000121121 LEI · 969500C656AA39O94N60 PA Financial and insurance activities
Open in API
Filings indexed 1,481 across all filing types
Latest filing 2024-03-18 Transaction in Own Shar…
Country FR France
Listing PA RF

About Eurazeo SE

https://www.eurazeo.com/en

Eurazeo SE is a global investment group specializing in private markets asset management. The firm operates across three core divisions: Private Equity, Private Debt, and Real Assets. Its Private Equity team supports companies at all stages of development, from startups to established enterprises, through investment strategies such as Buyout, Acceleration, and Venture capital. The Private Debt division provides tailored financing solutions, including Direct Lending and Asset-based Finance, primarily for mid-cap companies. The Real Assets division invests in European markets at the intersection of real estate and private equity, focusing on areas like transition infrastructure. Committed to responsible and sustainable growth, Eurazeo leverages its expertise to help its portfolio companies achieve long-term transformation and value creation.

Recent filings

Filing Released Lang Actions
Disclosure of transactions in own shares on March 11 to March 15, 2024
Transaction in Own Shares Classification · 98% confidence The document contains detailed tables listing transactions ('Détail transaction par transaction') involving the issuer 'Eurazeo SE', including dates, prices, quantities, and objectives like 'Annulation' (Cancellation) or 'Affectation aux VMP' (Allocation to VMP - likely treasury shares/own shares). This structure strongly indicates a report detailing the company's own share transactions (buybacks or sales). This aligns directly with the definition for 'Transaction in Own Shares' (POS). The presence of specific transaction dates (e.g., 11/03/2024) and detailed trade logs confirms it is the report itself, not just an announcement of a report.
2024-03-18 English
Déclaration hebdomadaire d'opérations effectuées du 11 au 15 mars 2024
Transaction in Own Shares Classification · 98% confidence The document contains detailed tables listing transactions ('Détail transaction par transaction') involving the issuer 'Eurazeo SE', including dates, prices, quantities, and objectives like 'Annulation' (Cancellation) or 'Affectation aux VMP' (Allocation to VMP - likely treasury shares/own shares). This structure strongly indicates a report detailing the company's own share transactions (buybacks or sales). This aligns directly with the definition for 'Transaction in Own Shares' (POS). The presence of specific transaction dates (e.g., 11/03/2024) and detailed trade logs confirms it is the report itself, not just an announcement of a report.
2024-03-18 French
EURAZEO SIGNS AN AGREEMENT TO SELL 100% OF PETERS SURGICAL’ SHARE CAPITAL TO ADVANCED MEDICAL SOLUTIONS GROUP PLC
Delisting Announcement Classification · 99% confidence The document announces a definitive agreement for Eurazeo to sell 100% of Peters Surgical's share capital to Advanced Medical Solutions Group plc. This is a major corporate transaction involving the sale of a portfolio company by an investment group. This type of event—a merger, acquisition, or major divestiture—is classified under 'M&A Activity' (TAR). The document details the parties involved, the strategic rationale, and the financial implications of the transaction.
2024-03-13 English
EURAZEO SIGNE UN ACCORD POUR LA VENTE DE 100% DU CAPITAL DE PETERS SURGICAL A ADVANCED MEDICAL SOLUTIONS GROUP PLC
M&A Activity Classification · 99% confidence The document is a press release dated March 13, 2024, announcing that Eurazeo has signed an agreement to sell 100% of the capital of Peters Surgical to Advanced Medical Solutions Group plc. This clearly describes a corporate transaction involving a merger, acquisition, or takeover proposal (the sale of a subsidiary). Based on the definitions, this falls under 'M&A Activity' (Code: TAR). The document is a formal announcement of the transaction details, not a general regulatory filing (RNS) or a report itself.
2024-03-13 French
Disclosure of the number of shares and the total number of voting rights as of February 29, 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'DECLARATION DU NOMBRE D'ACTIONS COMPOSANT LE CAPITAL ET DU NOMBRE TOTAL DE DROITS DE VOTE AU 29 FEVRIER 2024' (Disclosure of the number of shares and the total number of voting rights as of February 29, 2024). It explicitly cites French commercial code and AMF regulations regarding the disclosure of share capital and voting rights. This type of mandatory disclosure, which reports on the total number of shares and voting rights, is a specific regulatory announcement related to corporate structure and shareholder rights, but it is not a general regulatory filing (RNS) or a declaration of voting results from a specific meeting (DVA). It is most closely aligned with announcements concerning capital structure or shareholder information. Given the options, this specific declaration of the total number of shares and voting rights fits best under 'Declaration of Voting Results & Voting Rights Announcements' (DVA), as it is a formal declaration related to voting rights, even if it's not the *results* of a vote, but the *basis* for voting. However, since DVA is defined as 'Official results from shareholder votes at any general meeting (AGM or EGM)', and this is a routine monthly/periodic disclosure of the capital base, it is a very specific type of regulatory disclosure. Since there is no perfect fit for a routine 'Total Shares Outstanding/Voting Rights Disclosure', and it is a formal regulatory declaration, it falls between DVA and RNS. Given the content is purely about the count of shares and voting rights, and not the results of a specific vote, DVA is slightly less accurate than a general regulatory filing. However, if we look closely at the definitions, DVA covers voting rights announcements. Since this document is a formal, periodic declaration of the total voting rights basis, it is a strong candidate for DVA, despite the definition focusing on 'results'. If DVA is interpreted strictly as post-meeting results, then RNS is the fallback. Let's re-evaluate: This is a mandatory disclosure under AMF rules regarding the total number of shares and voting rights. This is a fundamental piece of information for shareholders preparing to vote or assessing their stake. It is a declaration related to voting rights. I will classify it as DVA based on the subject matter (voting rights declaration), even if it's not the final tally of a specific vote. The document length is short (2762 chars), but it is the report itself, not an announcement of a report. Confidence is high due to the explicit nature of the content.
2024-03-11 French
Déclaration du nombre d'actions composant le capital et du nombre total de droits de vote au 29 février 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'DECLARATION DU NOMBRE D'ACTIONS COMPOSANT LE CAPITAL ET DU NOMBRE TOTAL DE DROITS DE VOTE AU 29 FEVRIER 2024' (Disclosure of the number of shares and the total number of voting rights as of February 29, 2024). It explicitly cites French commercial code and AMF regulations regarding the disclosure of share capital and voting rights. This type of mandatory disclosure, which reports on the total number of shares and voting rights, is a specific regulatory announcement related to corporate structure and shareholder rights, but it is not a general regulatory filing (RNS) or a declaration of voting results from a specific meeting (DVA). It is most closely aligned with announcements concerning capital structure or shareholder information. Given the options, this specific declaration of the total number of shares and voting rights fits best under 'Declaration of Voting Results & Voting Rights Announcements' (DVA), as it is a formal declaration related to voting rights, even if it's not the *results* of a vote, but the *basis* for voting. However, since DVA is defined as 'Official results from shareholder votes at any general meeting (AGM or EGM)', and this is a routine monthly/periodic disclosure of the capital base, it is a very specific type of regulatory disclosure. Since there is no perfect fit for a routine 'Total Shares Outstanding/Voting Rights Disclosure', and it is a formal regulatory declaration, it falls between DVA and RNS. Given the content is purely about the count of shares and voting rights, and not the results of a specific vote, DVA is slightly less accurate than a general regulatory filing. However, if we look closely at the definitions, DVA covers voting rights announcements. Since this document is a formal, periodic declaration of the total voting rights basis, it is a strong candidate for DVA, despite the definition focusing on 'results'. If DVA is interpreted strictly as post-meeting results, then RNS is the fallback. Let's re-evaluate: This is a mandatory disclosure under AMF rules regarding the total number of shares and voting rights. This is a fundamental piece of information for shareholders preparing to vote or assessing their stake. It is a declaration related to voting rights. I will classify it as DVA based on the subject matter (voting rights declaration), even if it's not the final tally of a specific vote. The document length is short (2762 chars), but it is the report itself, not an announcement of a report. Confidence is high due to the explicit nature of the content.
2024-03-11 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.